Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02772770 · ClinicalTrials.gov registry record

Pediatric ACL: Understanding Treatment Options

A clinical trial of Anterior Cruciate Ligament Reconstruction, sponsored by Boston Children's Hospital.

Active
Registry status
765
Enrollment target
10
Study locations

NCT02772770: Active study of Anterior Cruciate Ligament Reconstruction, sponsored by Boston Children's Hospital.

NCT02772770 is a study of Anterior Cruciate Ligament Reconstruction that is active but no longer recruiting, run by Boston Children's Hospital. The registered enrollment target is 765 participants, above the 225-participant average among 11 other Anterior Cruciate Ligament Reconstruction trials with a reported enrollment target (240% higher). The trial reports 10 study locations across 8 states. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02772770, a study of Anterior Cruciate Ligament Reconstruction, is active but no longer recruiting, sponsored by Boston Children's Hospital.

ACTIVE NOT RECRUITING
Registry status
765 participants
Enrollment target
10
Study locations

Study Summary

Pediatric ACL: Understanding Treatment Outcomes (PLUTO) is a multi-center, prospective cohort study. Specific aims of PLUTO are to evaluate the safety and comparative effectiveness of non-operative treatment, as well as four operative treatments including (1) transphyseal ACL reconstruction (2) partial transphyseal ACL reconstruction, (3) physeal-sparing epiphyseal ACL reconstruction using the Anderson technique, and (4) physeal-sparing ACL reconstruction using the Micheli/Kocher technique in prepubescent and pubescent skeletally immature patients.

Primary Outcome

To compare outcomes associated with four surgical techniques performed to treat complete intrasubstance ACL tears in pre- and early pubescent children: (1) transphyseal ACL reconstruction (2) partial transphyseal ACL reconstruction, (3) physeal-sparing epiphyseal ACL reconstruction using the Anderson technique, and (4) physeal-sparing ACL reconstruction using the Micheli/Kocher technique.

Conditions Studied

Anterior Cruciate Ligament Reconstruction

Interventions

  • OTHER Non-operative treatment group will undergo standardized treatment which will include rehabilitation, bracing and certain activity restrictions
  • PROCEDURE Surgical technique: Transphyseal reconstruction
  • PROCEDURE Surgical technique: Partial transphyseal reconstruction
  • PROCEDURE Surgical technique: Physeal sparing reconstruction by the Anderson method
  • PROCEDURE Surgical technique: Physeal sparing reconstruction by the Micheli/Kocher method

Study Locations (10)

California

  • Stanford University Medical Center - Palo Alto
  • Rady Children's Hospital - San Diego

Ohio

  • Cincinnati Children's Medical Center - Cincinnati
  • Cleveland Clinic Foundation - Cleveland

Georgia

  • Children's Healthcare of Atlanta - Atlanta

Massachusetts

  • Boston Children's Hospital - Boston

Missouri

  • Washington University at St. Louis - St Louis

New York

  • Hospital for Special Surgery - New York

Pennsylvania

  • Children's Hospital of Philadelphia - Philadelphia

Tennessee

  • Tennessee Orthopaedic Alliance - Nashville

Trial Details

FieldValue
Enrollment Target 765 participants
Start Date 2016-09
Est. Completion 2030-12
Boston Children's Hospital

462 total trials

What the registry record for NCT02772770 still lists

NCT02772770 is an observational study that tracks outcomes without assigning an intervention. The registered 765 participants enrollment target is mid-sized for trials with a published cap, above the 225-participant average among 11 other Anterior Cruciate Ligament Reconstruction trials with a reported enrollment target (240% higher).

The record links to 1 condition, with Anterior Cruciate Ligament Reconstruction appearing as the primary indexed condition, and to 5 interventions - of which Non-operative treatment group will undergo standardized treatment which will include rehabilitation, bracing and certain activity restrictions is the first listed.

NCT02772770 lists 10 locations in 8 states (California, Ohio, Georgia).

Frequently Asked Questions

What is clinical trial NCT02772770 about?

NCT02772770 is a clinical study titled "Pediatric ACL: Understanding Treatment Options". Pediatric ACL: Understanding Treatment Outcomes (PLUTO) is a multi-center, prospective cohort study. Specific aims of PLUTO are to evaluate the safety and comparative effectiveness of non-operative treatment, as well as four operative treatments including (1) transphyseal ACL reconstruction (2) part...

What is the current status of trial NCT02772770?

This trial is currently active not recruiting. The enrollment target is 765 participants. The study started on 2016-09. Estimated completion is 2030-12.

What conditions does trial NCT02772770 study?

This clinical trial studies the following conditions: Anterior Cruciate Ligament Reconstruction.

What interventions are being tested in trial NCT02772770?

The interventions under investigation include: Non-operative treatment group will undergo standardized treatment which will include rehabilitation, bracing and certain activity restrictions (OTHER), Surgical technique: Transphyseal reconstruction (PROCEDURE), Surgical technique: Partial transphyseal reconstruction (PROCEDURE), Surgical technique: Physeal sparing reconstruction by the Anderson method (PROCEDURE), Surgical technique: Physeal sparing reconstruction by the Micheli/Kocher method (PROCEDURE).

Who is sponsoring clinical trial NCT02772770?

This trial is sponsored by Boston Children's Hospital, which has 462 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT02772770 being conducted?

This trial has 10 study locations across California, Georgia, Massachusetts, Missouri, New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Anterior Cruciate Ligament Reconstruction

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT02772770's enrollment target sits among peer trials

765 2nd of 11 the highest of 11 other Anterior Cruciate Ligament Reconstruction trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Anterior Cruciate Ligament Reconstruction trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT03789552 · 765 participants · Phase 3

    Outcome Research to Confirm the Anti-anginal Effect of T89 in Patients With Stable Angina

  • NCT07195591 · 766 participants · Phase 3

    Beginning Radiation Immediately With GammaTile at GBM Excision Versus Standard of Care

  • NCT04578665 · 764 participants · NA

    Human-like Robotic Controllers for Enhanced Motor Learning

  • NCT05579366 · 764 participants · Phase 1

    Rinatabart Sesutecan (Rina-S, PRO1184, GEN1184) for Advanced Solid Tumors (GCT1184-01/ PRO1184-001)

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Related registry views

Source: ClinicalTrials.gov NCT02772770, the US trial registry maintained by the National Library of Medicine. NCT02772770 (mid enrollment · multi site footprint · active not recruiting) retrieved and formatted by PlainTrial, see methodology.